Updated just now · Live
Stock analysis, price data, and AI-powered insights for Medicus Pharma Ltd (MDCX).
Medicus Pharma Ltd operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for MDCX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). MDCX Stock Intelligence Report. [stoxpulse.com/stocks/mdcx]
Disclaimer: The information on this page about Medicus Pharma Ltd (MDCX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Medicus Pharma Ltd.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Medicus Pharma Files Orphan Drug Designation To FD...
4d ago
Medicus Pharma Submits Orphan Drug Designation App...
4d ago
StoxPulse AI results for MDCX: Pulse Score 51.5/100. Primary sentiment trends from 7 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$13.5M
P/E Ratio
—
EPS
$-1.12
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Medicus Pharma Files Orphan Drug Designation To FDA For SkinJect To Treat Basal Cell Carcinoma In Participants With Gorlin Syndrome
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
EXCLUSIVE: Medicus Pharma To Present New Teverelix Data Highlighting Durable Hormone Suppression With Potential For Multiple Women's Health Indications
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline